Image of Illuminant research team in front of posterImage of Illuminant research team in front of poster
Back arrow
back

Clinical Research Team Presents Research at ASPN 2023

July 15, 2023

On Saturday, July 15th, members of our clinical research team traveled to Miami Beach, FL to present their work on emerging technologies in interventional percutaneous pain procedures at the 2023 American Society of Pain and Neuroscience (ASPN) Conference. To find out more about our research on this topic, be sure to read our article on our ASPN acceptance.

Research Associates, Sujay Ratna (left) and Juan Sebastian Arroyave Villada (right), presenting our poster at ASPN 2023.
Illuminant overhead equipmentIlluminant overhead equipment

Illuminant allows you to see everything you need to deliver the highest-quality surgical procedures all in one place, in real time.

Our Technology

Similar Articles

News

Illuminant Awarded Federal Grant from National Science Foundation

We are excited to announce that we have been awarded a federal grant from the National Science Foundation (NSF). This non-dilutive Phase 1 grant will provide funding to further develop and validate our technology’s application in spine surgery.

News

NVIDIA Accepts Illuminant into Inception Program

Illuminant has been accepted to NVIDIA’s Inception Program!

Blog

Illuminant Showcases Work to Johnson & Johnson

Ikaasa Suri, our Chief Clinical Officer, had the opportunity to showcase our work to the Ethicon, Inc. team at Johnson & Johnson.

Contact Us

Reach out to us to get a closer look at the future of surgical navigation

founders@illuminant.ai
5855 Green Valley Circle
Culver City, CA
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2023 Illuminant. All rights reserved.
Privacy PolicyTerms of Service

The Illuminant Surgical Navigation System is being designed with the intent to improve surgery. All information on this website represents the design goals of Illuminant Surgical and has not been evaluated by the United States Food and Drug Administration (FDA). The product has not been cleared by the FDA and is not for commercial sale in the United States.